Although extended pluripotent stem cells (EPSCs) have the potential to form both embryonic and extraembryonic lineages, how their transcriptional regulatory mechanism differs from that of embryonic stem cells (ESCs) remains unclear. Here, we discovered that YY1 binds to specific open chromatin regions in EPSCs. Yy1 depletion in EPSCs leads to a gene expression pattern more similar to that of ESCs than control EPSCs. Moreover, Yy1 depletion triggers a series of epigenetic crosstalk activities, including changes in DNA methylation, histone modifications and high-order chromatin structures. Yy1 depletion in EPSCs disrupts the enhancer-promoter (EP) interactions of EPSC-specific genes, including Dnmt3l. Yy1 loss results in DNA hypomethylation and dramatically reduces the enrichment of H3K4me3 and H3K27ac on the promoters of EPSC-specific genes by upregulating the expression of Kdm5c and Hdac6 through facilitating the formation of CCCTC-binding factor (CTCF)-mediated EP interactions surrounding their loci. Furthermore, single-cell RNA sequencing (scRNA-seq) experiments revealed that YY1 is required for the derivation of extraembryonic endoderm (XEN)-like cells from EPSCs in vitro. Together, this study reveals that YY1 functions as a key regulator of multidimensional epigenetic crosstalk associated with extended pluripotency.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756953 | PMC |
| http://dx.doi.org/10.1093/nar/gkac230 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Viral oncogene EBNALP regulates YY1 DNA binding and alters host 3D genome organization.
EMBO Rep
January 2025
Division of Infectious Disease, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
The Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNALP) is essential for the immortalization of naive B lymphocytes (NBLs). However, the mechanisms remain elusive. To understand EBNALP's role in B-cell transformation, we compare NBLs infected with wild-type EBV and an EBNALP-null mutant EBV using multi-omics techniques.
View Article and Find Full Text PDFPericytes Modulate Third-Generation Tyrosine Kinase Inhibitor Sensitivity in EGFR-Mutated Lung Cancer Cells Through IL32-β5-Integrin Paracrine Signaling.
Adv Sci (Weinh)
December 2024
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
EGFR-mutated lung cancer patients sometimes display restricted responses to third-generation tyrosine kinase inhibitors (TKIs), potentially attributable to undervalued input from stromal cells, notably pericytes (PCs). The study shows that PCs isolated from EGFR-mutated patients have a unique secretome profile, notably secreting IL32 and affecting signaling pathways and biological processes linked to TKI sensitivity. Clinical evidence, supported by single-cell RNA sequencing and multiplex immunostaining of tumor tissues, confirms the presence of IL32-expressing pericytes closely interacting with β5-integrin-expressing cancer cells in EGFR-mutated patients, impacting therapeutic response and prognosis.
View Article and Find Full Text PDFTargeting the transcription factor YY1 is synthetic lethal with loss of the histone demethylase KDM5C.
EMBO Rep
December 2024
Department of Immunology, TaiKang Medical School (School of Basic Medical Sciences), Wuhan University, 430071, Wuhan, China.
Article Synopsis
- Understanding how epigenetic modifiers like KDM5C work is crucial for developing cancer therapies.
- The study identifies the protein YY1 as a key interacting partner of KDM5C, revealing that their combined depletion has a strong antitumor effect.
- Dual targeting of KDM5C and YY1 leads to increased repression of critical genes involved in the cell cycle and apoptosis, hinting at potential combination therapies for cancer treatment.
Genome-Wide Profiling of H3K27ac Identifies TDO2 as a Pivotal Therapeutic Target in Metabolic Associated Steatohepatitis Liver Disease.
Adv Sci (Weinh)
December 2024
Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, 230032, China.
Article Synopsis
- H3K27ac is an important marker for active enhancers and is linked to metabolic dysfunction-associated steatotic liver disease (MASLD), which is not fully understood yet.
- A study found that H3K27ac levels and related gene activity are significantly increased in rats with MASLD due to a high-fat diet, identifying the gene TDO2 as a key player in abnormal fat accumulation.
- The researchers developed a nanoparticle-based treatment to inhibit TDO2, which effectively reduces liver fat and metabolic issues, suggesting that targeting the H3K27ac-TDO2-NF-κB pathway could lead to new treatments for MASLD.
USP1-mediated deubiquitination of KDM1A promotes the malignant progression of triple-negative breast cancer.
J Biochem Mol Toxicol
October 2024
Department of Thyroid and Breast Surgery, The Fourth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Article Synopsis
- This study explores the role of lysine-specific histone demethylase 1A (KDM1A) in triple-negative breast cancer (TNBC), revealing that KDM1A is highly expressed in TNBC tissues and contributes to cancer cell survival and aggressiveness.* -
- The research shows that the protein ubiquitin-specific protease 1 (USP1) stabilizes KDM1A, and its depletion reduces KDM1A levels, ultimately inhibiting TNBC progression.* -
- Additionally, Yin Yang 1 (YY1) is identified as a key regulator that increases KDM1A expression by binding to its promoter, highlighting the interconnected roles of YY1, KDM1A, and
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!